FDA mustn’t interfere with dying patients’ right to experimental treatments

Published June 22, 2018 4:00am ET



More than 1 million Americans die each year from a terminal illness. For those patients who are still fighting, recent passage of the federal Right to Try Act will expand access to potentially life-saving treatment before it’s too late. But this will only happen if the Food and Drug Administration faithfully applies the law and doesn’t stand in the way of patients seeking new hope.

The law bears the name of Matthew Bellina, one of the many Americans who stand to benefit.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.